<DOC>
	<DOC>NCT00517777</DOC>
	<brief_summary>To assess in moderate to severe Obstructive Sleep Apnea the effects of one year therapy with nighttime continuous positive airway pressure ventilation on the prevalence of metabolic syndrome and cardiovascular damage.</brief_summary>
	<brief_title>Continuous Positive Airway Pressure in Sleep Apnea Syndrome: Effects on Metabolic Syndrome and Cardiac Damage</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>moderate to severe sleep apnea syndrome cardiovascular diseases (coronary artery disease, stroke, peripheral artery disease) thyroid diseases diabetes</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>sleep apnea syndrome</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>cardiac remodelling</keyword>
	<keyword>continuous positive airway pressure ventilation</keyword>
</DOC>